Add
Compare:
Overview:
There are 14 differences and 7 similarities between Daytrana, Metadate ER
| Basic Information |
| Generic Name |
| Methylphenidate |
Methylphenidate |
| Class |
| Cns Stimulants |
Cns Stimulants |
| Prescription Generic Available |
| No |
Yes |
| Pregnancy cat. |
| C(us) |
C(us) |
| Approved Age |
| 6 And Older |
6 And Older |
| Legal Status |
| Schedule Ii (us) |
Schedule Ii (us) |
| WADA Category |
| S6 - Stimulants |
S6 - Stimulants |
| Dependence Liability |
| High |
Moderate |
| Excretion |
|
Urinary |
| Possible Side Effects |
| Skin Irritation, Some Loss Of Appetite, Weight Loss, Sleep Problems, Irritability, Tics. |
Some Loss Of Appetite, Weight Loss, Sleep Problems, Irritability, Tics. |
|
| Dosage, Usage and Forms |
| Routes (of administration) |
| Oral, Transdermal |
Oral |
| Dosage |
| 10–30 Mg Q Am |
10 Mg Q Am–30 Bid (max
60mg/day) |
|
Maximum daily dose |
| 30 mg |
60 mg |
| Duration |
| Long-acting |
Intermediate-acting |
| Duration - time |
| 8-12 H |
6-8 H |
| Chemical Data |
| Molecular mass (g/mol) |
|
269.77 G/mol |
| Half Life |
| 3-4 Hours |
3.4 Hours |
| Formula |
| C14h19no2 |
C14h19no2•hcl |
| Bioavailability |
|
30 % |
| Protein binding |
|
15 % |
| Metabolism |
| Hepatic |
Hepatic |